Exelixis, Inc. (EXEL) CFO Sends Update on Company’s Progress
During the William Blair 28th Annual Growth Stock Conference in Chicago, the CFO of Exelixis, Inc. (EXEL), Frank Karbe, presented on the company's corporate relationships with biotechnology and pharmaceutical companies, recent company funding, and other company news. Exelixis, Inc. is a developmental stage biotechnology company that has dedicated their efforts to the discovery and development of small molecule therapeutics for the treatment of cancer and other serious diseases. Mr. Karbe explained how Exelixis established important relationships with major pharmaceutical companies, "We are unique in the industry and have established a leadership position in a number of key targets and pathways…